Background. Routine medical microbiology diagnostics relies on conventional cultivation followed by phenotypic techniques for identification of pathogenic bacteria and fungi. This is not only due to tradition and economy but also because it provides pure culture needed for antibiotic susceptibility testing. This review focuses on the potential of High Resolution Melting Analysis (HRMA) of double-stranded DNA for future routine medical microbiology.
INTRODUCTION
While molecular-genetic techniques have been rapidly implemented in detection and identification of microorganisms that cannot be cultivated, grow very slowly in culture or require special techniques, their use in the case of other microbes is still limited. For bacterial species that have no special requirements for growth, conventional cultivation followed by phenotypic identification still represents the golden standard in routine medical microbiology not only because of tradition and economy but also because it provides pure culture needed for antibiotic susceptibility testing. In the case of fungal species, susceptibility testing is typically not performed: However, conventional techniques are well-proven and recovery of a limited number of cultures of a rather broad spectrum of yeast and mold species discourages development of new techniques and implementing them for routine use. On the other hand, accurate and detailed genetic characterization became increasingly important when the differences among species and genotypes were recognized as fequently playing an important role in health and disease. Therefore, we expect the routine availability of the newly available elegant technique of high-resolution melting analysis (HRMA) in medical microbiology laboratories should provide a strong stimulus in this field. This is already envisioned by the growing number of specific HRMA applications published in medical microbiology recently. In this review, we will therefore focus on this fermenting topic. The principle and important technical aspects of melting analysis will be elucidated first for those unfamiliar with the technique, followed by a summary of the remarkable repertoire of its applications already introduced into diagnostic medical microbiology, bacteriology and mycology in particular.
TECHNICAL ASPECTS OF MELTING ANALYSIS

Principle of the technique
As widely known, the course of thermal double-stranded DNA (dsDNA) denaturation, shortly called DNA melting, largely depends on two basic features of a dsD-NA molecule, namely length and sequence. Because the two strands of dsDNA are bound together by hydrogen bonds between base pairs, the longer the molecule, the more thermal energy is needed for its separation (melting). In addition, G-C base pairs form 3 hydrogen bonds, while A-T pairs only two. Hence, with more G-C pairs present in a given molecule, more energy is also needed for melting. This provides a unique link between both the length and sequence of a dsDNA molecule and its easily measurable physical characteristic. Historically, melting properties of dsDNA were monitored by measuring UV absorbance (hyperchromic effect). Such analysis required μg amounts of DNA and often took hours to complete.
With the introduction of the first real-time PCR instrument that combined thermal cycler with a fluorimeter, fluorescent DNA melting analysis became popular at the end of 1990s. This analysis requires only ng amounts of DNA and small sample volumes allow both better temperature control and fast melting rates of 0.1-1.0 °C/s, shortening the melting analysis time to a few minutes.
Typically, PCR amplification of a desired DNA region precedes DNA melting analysis for all kinds of different purposes. Due to its rapid and simple performance, melting analysis competes successfully with traditional techniques of post-PCR analysis, like conventional gel electrophoresis, analysis of single-stranded conformational polymorphism (SSCP), denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) (ref. 1 ). The best system for detection, quantification and examination of sequence specificity of PCR products would work simultaneously with amplification and no further analysis would be necessary 1, 2 . A closed system of this kind can be achieved by using dsDNA fluorescent dyes in melting analysis or fluorescent labelled allele-specific probes in real time PCR (ref. 1 ). In addition, both techniques can be combined in one assay using compatible fluorescent chemistries. Alternatively, asymmetric PCR can also be combined with the use of unlabelled probes, where dsDNA fluorescent dyes allow for the monitoring of probe/DNA melting behaviour. Typically, melting analysis provides valuable data in the field of pre-sequencing analysis and is even able to replace sequencing in specific areas of analysis. Its applications span wide areas of research and diagnostics, including mutation discovery (gene scanning), genotyping of single nucleotide polymorphisms (SNPs), and DNA methylation analysis.
When monitoring the process of DNA melting, we should bear in mind that it is not a linear event, because cooperative forces enhance the stability of a dsDNA molecule in addition to mere hydrogen bonding, and also regions of different AT/GC ratio are present along molecules of different sequences. Thus it typically follows a sigmoid curve (Fig. 1a) , but it can also follow a more complex pattern in longer molecules. The process of denaturation is most simply characterized by T m (melting temperature) which is defined as a temperature where 50% of present dsDNA molecules are already denaturated into single-stranded DNA (ssDNA).
In fluorescent melting analysis, a fluorescent dsDNA binding dye is added to the reaction mixture prior to amplification. Thus the PCR products already harbour the dye intercalated in their dsDNA. It is also possible to add the dye after PCR itself which may be useful in some cases to avoid dye interference with PCR amplification and/or prevent an increase in optimum annealing temperature of primers. When a PCR product is melted later, molecules of the intercalated fluorescent dye are released from the denatured DNA chain. This is observed as a decrease in fluorescence, and can be plotted as a melting curve of unique shape (Fig.1b) .
Acquisition and processing of melting data
Typically, the whole process of PCR amplification and melting analysis takes place in a closed tube without manual intervention 2 . The PCR amplification and melting analysis are either both performed in a real-time PCR instrument that also enables melting analysis, or the PCR tube or capillary are transferred from a thermal cycler to a melting instrument. A melting curve is plotted based on fluorescence data acquired during melting as a function of dissociation temperatures during heating of the sample. Thus denaturation of a PCR product saturated by a dsDNA dye is observed as a sudden decrease of fluorescence near T m (ref.
2 ). Before this sharp decrease can be observed, a constant slow decrease in fluorescence with temperature increase is observed. This so-called premelt domain reflects just physical changes in the relative fluorescence intensity caused by increasing temperature. Once a sharp decrease is observed, the dsDNA melting is reflected in the melt domain of the curve, followed by another constant slow decrease in fluorescence with temperature when dsDNA melting is complete and the dsDNA melting domain flows into post-melt domain (all Fig. 2a ). When acquiring fluorescence data during heating of a sample containing dsDNA, the interval between start and stop temperature for data acquisition has to be set wide enough to include the process of melting represented by sharp decrease of fluorescence.
It should be mentioned that the melting behaviour of a PCR product is affected not only by its intrinsic properties but also by the concentration of the dsDNA dye and the rate of temperature transition 2 . In addition, PCR amplification also results in different yields of PCR product which further influences the melting analysis. Therefore, reaction parameters should if possible be optimised for a given assay and then kept unchanged for reproducible performance, including the PCR yield. However, even with best optimisation, exactly constant and reproducible yields can never be achieved. Thus each of the curves representing raw fluorescent melting data starts at a different point on the Y axis, corresponding to the relative fluorescence intensity of the sample at the beginning of analysis. Therefore, individual melting curves and their characteristics based on such data cannot be compared directly; they have to be normalised before any comparison. This is done through software-driven numerical recalculation of individual melting data points which results in unifying the starting values of all curves on 100% relative fluorescence intensity and their endpoints at 0% relative fluorescence intensity (Fig. 3a) . In order to provide reference data for such normalisation, parts of the pre-melt and post-melt domains that are considered unaffected by melting behaviour of the dsDNA have to be defined first. Selection of such reference intervals cannot be automated and has to be optimised empirically for each newly developed assay, because choosing different intervals results in differences in final shaping of normalised melting domains. At least, choice of intervals which result in apparently unnatural or bizarre appearance of normalised melting curves has to be avoided. Once optimised, the The potential of high resolution melting analysis (HRMA) to streamline, facilitate and enrich routine diagnostics in medical microbiology same intervals have to be set in repeated experiments of the same assay to secure reproducibility of melting data interpretation. Adjustment of melting data along the X axis (temperature) may also be advantageous in addition to vertical normalisation of melting data described above (Fig. 3b) . Namely, increased concentration of an intercalating dye can cause a shift of melting curves to higher temperatures. The same is true when dsDNA concentration in one sample is considerably lower than in other samples because this moves the dye/dsDNA ratio towards relatively higher concentration of dye. If more dye molecules saturate the DNA duplex in one sample than others, the more they contribute to the stability of the duplex and thus increase its melting temperature relatively. The whole melting curve is then shifted to the right along the X axis. In addition, rapid temperature transitions during denaturation can shift melting curves to higher temperatures as well 2 . Last but not least, well-to-well temperature variation in block-type melting instruments always requires temperature shift normalization for proper interpretation of melting data. For this reason temperature shifting normalization is typically necessary in block-type melting instruments but in the case of air-controlled melting instruments with rotary design this is only a desirable or unnecessary.
After desirable normalization is performed, derivation of melting data can be performed, which in many cases enables better visual reading of differences between melting curves and also offers convenient accurate reading of T m . Derivative curves are typically constructed by calculating the first negative derivation of fluorescence with temperature (-ΔF/Δt). In effect, such transformation of a melting curve results in a plot that shows a peak, representing the melting domain of a dsDNA molecule (Fig. 2b) . In its first portion, a derivative curve corresponds to the pre-melt domain where absence of marked decrease in relative fluorescence results in a linear, flat appearance. However, once the fluorescence starts to decrease sharply with the beginning of dsDNA melting, its negative derivation plots a sharp increase in the derivative curve. After the sigmoid curve of decreasing fluorescence reaches inflexion point and the decrease in fluorescence decelerates, the negative derivative curve reaches a peak value and starts to drop again. This inflexion point in the sigmoid normalized curve and apex of the peak in the derivative curve both represent T m of the dsDNA molecule melted. Obviously, it is much easier to read a peak in a derivative curve than identify the inflexion point in a sigmoid curve. Shorter PCR products typically melt with a single domain and a single peak, whereas more complex longer molecules may melt differently in different stretches, resulting in complex melting domains and more than one peak in a derivative curve. This should also be kept in mind when focusing on a target for PCR amplification followed by melting analysis. Melting analysis has traditionally been most widely used in the field of SNP scanning and genotyping where the most extensive experience has also been accumulated. However, even in this field, the number of melting domains optimal for analysis remains controversial 3 . Apparently, different settings and targets of interest may require different strategies to achieve best reproducible and readable data. Overall, derivative curve provides better clues for interpretation of melting behavior and differentiation of sequence variants in many cases due to better readability of T m , and difference in the height and shape of peaks which may also improve visualizing differences in melting domains.
The shape and T m of a dsDNA melting curve is a function of its GC content, length, and sequence 2 . With dif- ferent molecules, T m and shape of its melting curve can vary over a wide range. According to empirical formulas, duplexes with 0% GC content melt at 41 ºC lower than 100% GC duplexes. When the GC content is the same in products of different length, the smaller product should melt at lower temperature and thus be easily distinguishable 2 . Differences in melting curve shapes, especially in regions which reflect minute sequence differences in melted dsDNA molecules, can be analyzed in detail by subtracting all curves from a reference curve (e.g. a curve obtained with a wild-type sequence/allele). This helps to cluster samples automatically into groups that have similar melting curves. Clustering of curves is simply evaluated visually and can be very helpful and reliable particularly in SNP assays if validated carefully (so-called differential plot). Typically, those melting curves obtained from individuals whose one allele is mutated and who are thus heterozygotes, cluster together as opposed to curves obtained from wild-type homozygotes. Such analysis is particularly helpful both in genotyping and mutation scanning, including screening for new, unknown mutations (in microbiology see e.g. Issa et al. 4 ).
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Recently, another type of quantitative numerical comparison of complex melting curves was proposed which can be useful for targeting highly variable sequences useful e.g. for species identification in microbiology (Fig. 4) . This approach was first used in processing of McRAPD data 5 , which can be useful both for species identification and strain typing. Briefly, normalized fluorescence values measured at each temperature point during melting analysis are subtracted in each pair of compared curves. Then, the sum of these subtracted values represents absolute numerical distance between two curves. After such distances are assigned to all pairs of curves studied, the highest value of 1.0 relative distance is assigned to the highest absolute distance obtained and the other absolute distances are re-calculated relatively. A matrix of such relative distances then represents a matrix of similarity coefficients and can be used to calculate tree data for a cladogram that will cluster the curves according to their degree of similarity, thereby providing visually easily readable comparison of similarity between large numbers of complex melting curves.
Fluorescent dsDNA specific dyes and High-Resolution Melting Analysis (HRMA)
As real-time PCR became a standard method both in research and routine use, many improvements in the area of fluorescent intercalating dyes were made. Many dyes were tested and evaluated as compatible with PCR chemistry and then became available for product staining as well as quantification during qPCR (Table 1) . Several other intercalating fluorescent dsDNA dyes were not tested for PCR-compatibility and some of these may also prove to be useful. Further improvement of the technique came with the introduction of High Resolution Melting Analysis (HRMA) which can be performed on melting instruments that are capable of acquiring fluorescence data at high density during DNA melting (approx. 50 data points are acquired for every 1 °C). When this technology was introduced, some of the dyes turned out to be more appropriate than others for HRMA. Also, some of the dyes showed better performance in specific fields of detection. For best performance, a dsDNA dye has to show low toxicity for PCR and high saturation of the dsDNA molecule. Low toxicity dyes can be included in the PCR reaction during its assembly and thus enable post-PCR melting analysis without opening the reaction tube. This is both convenient and time saving and it significantly reduces the risk of carryover contamination of future amplification reaction. Saturating dyes improve the resolution and accuracy of melting analysis in contrast to low saturation dyes not only because of increased fluorescence, but also because low saturation dyes redistribute from one part of a dsDNA molecule to another during melting to some extent in contrast to saturation dyes which show low dy- Melting curves of RAPD products are compared by calculating absolute distance between each pair of samples; relative distances are then recalculated to prepare a matrix of relative distances that are used to calculate tree data using e.g. the UPGMA algorithm. For details see text and Trtkova et al. 5 .
6 L. Ruskova, V. Raclavsky namic redistribution 11 ( Fig. 5 ). These requirements are met by the so-called third generation intercalating fluorescent dyes, namely SYTO 9 (Invitrogen Corp. Carlsbad, CA, USA), LCGreen (Idaho Technology Inc., Salt Lake City, UT, USA) and EvaGreen (Biotium Inc., Hayward, CA, USA).
All of the third generation dyes are declared to show high stability, low inhibition of PCR and high saturation. However direct comparison of their performance in HRMA is missing. Results of comparisons of individual dyes to the conventional SYBR Green I dye are cited when respective dyes are described. Obviously, results of any such comparison would also depend upon the specific application for which the dyes would be tested. Only one group directly compared more than 2 dyes and concluded LCGreen Plus detects heterozygotes better than SYTO 9, which is better than EvaGreen, which is better than SYBR Green I (ref. 16 ). Of course, when choosing a dye for a specific HRMA application, excitation and emission characteristics should first be confronted with the real-time and melting instrumentation available because not all instruments are compatible with all of the dyes available. Then inter-run variability of melting data obtained with different dyes, T m of individual melting peaks in particular, should be evaluated further for the best choice in a specific application. Last but not least, economy of performance can also play a significant role because of marked differences in pricing of individual dyes. When the utmost precision of HRMA for the purpose of SNP genotyping and homozygotes/heterozygotes genotyping is not the primary goal, less accurate but more economic options may be preferred. This is true for instance when gross differences in melting temperatures need to be evaluated e.g. for species identification purposes in microorganisms, as will be reviewed later.
Limitations of melting curve analysis
As any other technique, melting curve analysis has its limitations and potential pitfalls. Firstly, fluorescent intercalating dyes can bind to any dsDNA molecule, including primer dimers, and the detection of desired products is therefore dependent on product specific PCR (ref.
2 ). Whereas conventional gel electrophoresis of PCR products can usually easily unravel potential non-specific byproducts of amplification, fluorescent dyes lack sequence specificity and any non-specific by-products will bias the results of melting analysis. Therefore, closed-tube PCR-HRMA assays that omit conventional gel electrophoresis have to be optimised carefully and their performance should be strictly controlled if used for diagnostic purposes.
Secondly, all the components present at the time of melting analysis or during PCR amplification have a great impact on the melting curve shape and position. The absolute position and width of a melting curve are affected by dye concentration and temperature transition rates. Finer resolution is available with slower transition rates and greater sample homogeneity 2 . In addition, although many commercial platforms are available for real-time PCR and HRMA or HRMA separately, significant differences have been described in the uniformity of melting data obtained from different instruments when performing the same assay 17 . Thus, again, PCR-HRMA assays have to be optimised carefully for reliable performance on the same platform and using the same reagents. On the other hand, such optimisation efforts are typically adequately rewarded by high-throughput, economy, and simple and accurate performance of HRMA or PCR-HRMA. In addition to prevention of carryover contamination mentioned above, HRMA also provides much more information on the product then mere molecule length visualization, namely sequence-dependent shape of the curve and its 
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T m , enabling differentiation of products of the same size but different sequence.
MELTING ANALYSIS IN MEDICAL MICROBIOLOGY
Application potential in specific fields
In comparison to conventional approaches, various molecular-genetic techniques, in vitro nucleic acid amplification in particular, have led to improvements in the diagnosis of infectious diseases and to the detection time reduction, for overview see e.g. Espy et al. 18 . Such techniques can be typically performed either on primarily sterile clinical samples to speed up the process of detection and identification, or on pure culture of microorganisms when speed of detection is not critical and antibiotic susceptibility testing is also desirable. Molecular methods can be extremely helpful when conventional diagnostics is difficult and other tests are not reliable. The advent of real-time PCR revolutionized molecular techniques in medical microbiology, for overview see Espy et al. 18 . Combination of PCR and HRMA can contribute to the advantages of molecular-genetic techniques mainly by replacing post-PCR techniques or labeled probes that are not only more laborious but typically also more costly.
Generally, PCR-HRMA can be applied in three areas in medical microbiology, i.e. for species identification, for strain typing and also for genotyping of specific genes (allele detection). Detection and identification go hand in hand when performing PCR-HRMA on clinical sample directly, but as with any molecular-genetic technique, PCR-HRMA can of course also be applied on pure culture already recovered by conventional cultivation. Because conventional phenotypic identification techniques are well elaborated for routine use, molecular techniques, incl. PCR-HRMA, are only under development in the field of routine pure culture identification. In contrast, molecular-genetic typing of microorganism for epidemiological purposes is by large the most widely adopted genetic approach in medical microbiology because of its superior discriminatory power compared to phenotyping techniques. However, it is typically performed only in advanced laboratories retrospectively. Last but not least, molecular-genetic techniques also predominate when detection of specific alleles and/or genes is desired in particular species by advanced laboratories.
Except for nucleic-acid free prions, PCR-HRMA is applicable to any bacterial, viral or parasite species and has the potential to streamline the process of characterization of isolates for all the purposes listed above. Compared to hybridization or sequencing, which can serve the same purposes, HRMA offers an economic closed-tube approach performed instantly after PCR amplification and suitable for automation in future. For this reason, it is expanding in microbiology as reflected in new applications published at a growing pace. As with any new microbiological method, however, HRMA is firstly implemented on microorganisms causing serious diseases, where speed of any diagnostic test is crucial. In the next section, we will summarize HRMA applications published in the fields of species identification, strain typing and genotyping of specific alleles. The use of HRMA in detection of microorganisms will not be discussed separately because generally all the techniques suitable for HRMA species identification should also be applicable for detection in clinical samples following appropriate DNA extraction and assay optimization. However, when broad-range primers are used that are able to amplify DNA from more then one species, the use of HRMA is limited in clinical samples that harbour more then one species. This is because broad-range PCR primers will in such case amplify the same locus but with variable sequences in different species in parallel. Then, melting of a mixture of such variable amplicons will result in a mixed melting curve where individual melting behaviour of any of the mixed amplicons cannot be differentiated retrospectivelly. Therefore, those systems developed for broad-range detection can be applied only on primary sterile samples, where only single species can typically be expected, whereas narrowrange systems should also be applicable in most cases of samples containing mixed microbiota. Nevertheless, extraction of bacterial or fungal DNA of quality suitable for HRMA can be problematic from clinical samples in some cases. For better overview, all the applications discussed below are also summarized separately (Table 2) .
Melting analysis for species identification purposes
An amplification target useful for species identification should harbor both conserved sequences well suited for primer design and variable sequences that can serve subsequent identification. The degree of conservation and variability required can vary depending on the spectrum of species desired for amplification and identification. When panfungal or panbacterial coverage is the goal, the highest degree of conservation is paramount. In such cases, however, it is a major challenge to achieve a degree of product variability sufficient for reliable differentiation and identification of all targeted species as well. Following amplification, either the whole product can undergo melting analysis or a product-probe hybrid can be examined. Also, more amplification targets can be analyzed in parallel, either separately or in a multiplex reaction. In reality, true panbacterial coverage is hardly possible; however, coverage of e.g. all aerobic bacterial species potentially significant in health and disease should be feasible. Such strategy is then termed broad-range amplification. For evolutionary reasons, the 16S rRNA gene in bacteria and the 18S -ITS1 -5.8S -ITS2 -28S rRNA transcription unit in fungi which are both highly conserved and contain variable sequences characteristic for particular species, are most widely used for broad-range amplification. The fact that these regions have long been studied in detail also speaks in their favor because sequence data of rRNA genes are generally available in databases, even for bacterial and fungal species that are otherwise rarely studied.
Other genes conserved across kingdoms may represent an alternative to the rRNA genes, as described e.g. by Santos 5, 20, 21 . In the field of broad-range bacterial species identification, Klaschik et al. 22 were the first to develop a PCR and melting analysis assay using 2 probes for identification of 17 common bacterial species. In 2006, Cheng et al. 23 differentiated and identified 46 bacterial culture colonies representing 25 clinically important species using a LightCycler real-time PCR instrument for amplification of the 16S rRNA gene in the presence of the LC Green I fluorescent dye and a HR-1 melting instrument for melting profiles, without using any probe. Simplicity and smartness of this assay that promised rapid and economic bacterial species identification in future was instantly recognized and commented on in Editorial 24 . However, a well-proved broader coverage is desirable for routine use. So far, the best achievement towards an optimum system was made by Yang et al. 25 , who covered 100 clinically important bacterial species, though, reproducibility and specificity of this assay in routine use still has to be evaluated.
In the field of routine broad-range identification of fungal species, the McRAPD approach was the first technique that successfully implemented melting analysis 20 . It performs well in identification of pure culture of pathogenic yeast species and has its strong point in partial strain subtyping 5 , that can be particularly useful for epidemiological surveillance and that also has the potential to discover new cryptic yeast species in future as happened with RAPD in the recent past (Candida dubliniensis vs. C. albicans, Candida orthopsilosis and metapsilosis vs. C. parapsilosis). Owing to the principle of RAPD, its interlaboratory reproducibility will always be limited however although it can outdo conventional techniques in several aspects when optimized carefully 5 . It should also be noted, that because of the digital data obtained in melting analysis the McRAPD approach can be used for automated strain typing, as demonstrated by Hamal et al. 26 . For those who do not want to spend too much time with optimization and who also resign on typing for epidemiological purposes, specific amplification targeting yeast ITS1 and ITS2 regions should be very useful 27 . Both of the above assays are however suitable only for identification of pure culture recovered by cultivation because both McRAPD and ITS primers will amplify variable sequences in variable species. Then, when mixed culture would be processed, a mixture of variable amplicons would result in a mixed melting curve during HRMA and it would be impossible to differentiate individual melting behaviour of any of the mixed amplicons retrospectivelly. When seeking a rapid diagnostic assay performed directly on clinical samples, a system that detects a narrower range of the most important yeast and mold pathogens with high sensitivity, accuracy and reproducibility should be used. Dozens of such systems were published using real-time PCR with probes but none of them were widely accepted. The assay developed by Schabereiter-Gurtner et al. 28 combines good targeting (group-specific and universal primers) with species-specific biprobes in one reaction mixture, analyzed by melting analysis. In our opinion, this is the best one elaborated for routine use.
Although broad-range species identification is the most attractive application of HRMA in routine diagnostic microbiology, in many areas, narrow-range or genus-range systems may be extremely helpful as well. For instance, species-level identification of a staphylococcal isolate can be highly important as staphylococci cause a variety of serious infections and are threatening public health worldwide. It is known that in 30% of nosocomial infections and in 50% of nosocomial septicemia, coagulase-negative staphylococci (CoNS) are most commonly isolated 29 . Rapid and accurate identification based on HRMA can e.g. facilitate proper differentiation of true bloodstream infections caused by the same repeatedly recovered CoNS species in contrast to transient occurrence of changing species in blood samples of high-risk patients. In the study of Skow et al. 30 , unique melt profiles of product-probe hybrids resulting from sequence variations were observed and identification of 110 staphylococcal isolates achieved nearly 100% accuracy. Another good example is the system that targets the 16S rRNA gene in Nocardia strains 31 . Nocardiosis is usually an opportunistic infection, most commonly present as pulmonary disease. Its definitive diagnosis depends on microbiological identification and cultivation is time consuming (2 weeks of microbiological cultivation and susceptibility tests in contrast to 1 day PCR-HRMA assay). Similar to Nocardia sp., rapid performance and high intra-genus resolution are also very important in detection and identification of mycobacterial pathogens. In particular, differentiation of M. tuberculosis from nontuberculosis mycobacteria (NTM) has primary importance in the control of the infection and in choice of antimicrobial therapy. Although there are several commercial tests for mycobacteria identification available as Accuprobe (Gen-Probe Incorporated, San Diego, California), these require growth in culture to identify four commonly encountered and/or clinically significant mycobacteria reliably. The GenoType ® MTBC (Hain Lifescience GmbH, Nehren, Germany), a DNA•Strip® technology based test able to identify 40 Mycobacterium species, is rather similar. Another alternative is the INNO-LiPA line probe assay (Innogenetics N.V., Ghent, Belgium) for detection of mycobacteria and their identification at the species level but the test is costly. In addition, COBAS Amplicor real-time PCR assay followed by probe hybridization detected by colorimetric reaction (Roche Diagnostics, Mannheim, Germany) is available for mycobacterial detection and identification. All of these commercially available systems are laborious and less economic than PCR-HRMA. Then, Shrestha et al. 32 developed a real-time PCR detection with 2 probes followed by melting curve analysis for differentiation of nine NTM species. This assay was comparable to COBAS 9
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Amplicor and, in addition, it also appropriately characterized three acid-fast bacillus positive clinical specimens that contained M. avium, M. intracellulare, or M. kansasii as containing NTM rather than M. tuberculosis, in a parallel study 32 . Melting analysis was also demonstrated to be successful in inter-species differentiation of the M. chelonae-abscessus group that consists of M. chelonae, M. abscessus and M. immunogenum that are difficult to distinguish in the clinical laboratory 33 . A major contribution to rapid and accurate differential identification of Mycobacterium species was provided by the development of a real-time PCR with 21 HybProbes that identified 25 different Mycobacterium species based on melting data 34 . Differentiation of the pathogenic amoeboflagellate Naegleria fowleri from nonpathogenic Naegleria species using a single primer set and intercalating dye SYTO9 for real-time PCR and melting curve analysis of the ITS1-5.8S rRNA-ITS2 region is another good example of useful narrow-range differentiation of pathogenic species from their benign counterparts that is particularly useful for monitoring of bathing water, water supplies, and cooling systems 35 .
Melting analysis for genotyping purposes
Although melting analysis for the purpose of species identification can also be considered a genotyping approach, genotyping in the narrow sense means determination of specific genotypes of strains or alleles of genes. This is particularly useful for either epidemiological analysis and/or surveillance or for detection of alleles underlying clinically relevant phenotypes, e.g. in antibiotic resistance genes, virulence genes etc. In the field of strain typing, a recently developed well-directed and carefully elaborated assay nicely demonstrates the versatile power of HRMA in genotyping in the case of MRSA typing for epidemiological purposes 36 , a hot topic in medical microbiology. The ongoing effort to develop an HRMA typing scheme for Campylobacter jejuni and C. coli represents another good example of a well-elaborated approach. Namely, Price et al. 37 first developed a HRMA assay for interrogating the hypervariable CRISPR (cluster, regularly interspaced short palindromic repeats) locus of Campylobacter jejuni. To improve the power of resolution and extend the spectrum to C. coli, the same group elaborated an HRMA approach to detection of sequence variants of the flaA flagellin gene 38 . Because of its easy and rapid performance and potential for full automation, melting analysis of RAPD products may also be useful for epidemiological surveillance in the future. Whereas MLST is a reference approach for large scale surveillance and for population biology studies, there also remains a need for rapid, less laborious and cheap approaches, such as McRAPD, on a local scale . McRAPD may be usefull mainly in such species where other molecular typing schemes are not easily available or are laborious, e.g. for serovars of Leptospira as demonstrated by Tulsiani et al. 39 , or for less frequently occurring yeasts as demonstrated by Hamal et al. 26 in the emerging pathogenic yeast C. lusitaniae. Comparison of McRAPD with MLST data in five Gram-negative bacterial species showed that McRAPD could be used to rapidly identify major clones of these species, including multidrug-resistant and particularly virulent clones 21 . It can also serve typing of pathogens where RAPD typing schemes are well-established and there is no need to develop more sophisticated molecular approaches in the near future, e.g. in Aspergillus sp. 40 . In the field of virology, Lin et al. 41 developed high resolution melting analysis for subtype differentiation of the influenza A virus and for detection of newly emerging variants. The influenza B virus has also been studied using the melting curve analysis by Nakagawa et al. 42 , who demonstrated that the assay not only detected its antigenic variants but also allowed for more precise analysis of the antigenic shifts in the influenza B virus. A HRMA assay detecting and genotyping noroviruses directly from stool samples was also developed and successfully validated 43 . Apropos the detection of virulent genotypes, Reischl et al. 44 developed a set of real-time PCR assays with melting analysis of product probe-complexes targeting enterotoxin genes in enterotoxigenic Escherichia coli (ETEC). Makinen et al. 45 focused on Bordetella pertusis with the aim of rapid gene typing of gene variants of the pertussis toxin using hybridization probes melting curve analysis. In order to obtain a reliable tool for detection of Bacillus anthracis and B. cereus, Kim et al. 46 developed a multiplex real-time PCR melting curve analysis. A high degree of relatedness was demonstrated by several methods. Most of them failed in discriminating among some members of the B. cereus group. While virulence is defined by the presence of both virulence plasmids, either of these can be lost, in the laboratory or in nature, generating 4 different genotypes. The discrimination among B. anthracis and B. cereus is then difficult. The melting analysis assay was able to provide a rapid, inexpensive and sensitive tool to simultaneously detect, from purified genomic DNA, all B. anthracis virulence genotypes and near-neighbor B. cereus group chromosomes 46 . De Medici et al. 47 performed a specific reaction with primers targeting the region coding for a major subunit protein of a fimbrial structure on the surface of Salmonella enterica serotype Enteritidis. Specificity of the reaction was determined by melting analysis. Stephens et al. 48 tested successfully the hypothesis that HRMA can be useful for differentiation of spa alleles in methicilin-resistant Staphylococcus aureus (MRSA) isolates.
In the field of antibiotic treatment and resistance, the extended-spectrum beta-lactamases (ESBLs) represent a significant challenge. For this reason, several HRM assays were developed to detect mutations or alleles responsible for this phenotype. Chia et al. 49 developed a multiplex PCR to identify bla SHV , bla CTX-M-3 -like and bla CTX-M-14 -like genes and also modified a previously described SHV melting-curve mutation detection (MCMD) method 50 to rapidly differentiate the 6 bla SHV genes prevalent in Taiwan. Specific detection of bla VIM and bla IMP metallo-β-lactamase genes in a single real-time PCR was tested by Bisilkis et al. 51 . The genes were clearly differentiated into four groups (bla VIM-1 -like, bla VIM-2 -like, bla IMP-1 -like, and bla IMP-2 -like) by melting curve analysis with two probes. On the other hand, Mendes et al. 52 designed a multiplex system able to detect and differentiate 5 metallo-β-lactamase genes without the use of probes. As for other types of antibiotic resistance genes, Fukushima et al. 53 studied, developed and validated a rapid single step PCR-melting assay for genotyping Streptococcus pneumoniae strains, targeting four quinolone resistance-determining region (QRDR) positions that are most frequently associated with fluoroquinolone resistance and Alfaresi et al. 54 focused both on the presence of clarithromycin resistance genes and virulence attributes (cagA and vacA genes) in Helicobacter pylori, both in subcultured isolates and in gastric mucosal biopsy samples. Their real-time PCR and melting curve analysis assay was able to identify patients suffering from H. pylori infection and in addition to identify strains harboring mutations associated with clarithromycin resistance.
CONCLUSIONS
This review shows that from the increasing number of newly developed applications, implementation of the PCR-HRMA approach is a vigorously fermenting field in all areas of medical microbiology. Although no technique can be expected to resolve all the challenges of modern diagnostic microbiology, a combination of colony-PCR with HRMA has the potential for economic, rapid and accurate characterization of bacterial cultures that can replace conventional phenotypic techniques. PCR-HRMA also has great potential to facilitate, streamline and expand the process of bacterial culture characterization. We can envisage a model situation, where a potentially pathogenic bacterial species is identified in the first step by PCR-HRMA and based on the result of identification, further differentiation of specific genotypes, genomovars or virulence genes may be desired to clarify its true role in health and disease. Although PCR-HRMA can never replace antimicrobial susceptibility testing, it can provide rapid detection of specific resistance genes which cannot be easily or rapidly detected by conventional phenotypic techniques. In all of these cases, template genomic DNA is already extracted from the particular bacterial isolate for the purpose of initial species identification, thus enabling rapid performance of supplementary PCR-HRMA genotyping assays immediately after their need emerges. In the limited number of cases where a PCR-HRMA assay does not produce an unequivocal ultimate result, the option of supplementary sequencing using the same extracted DNA sample is still available. If an economic pyrosequencing technology is applied, such preliminary HRMA characterization (pre-sequencing screening) of the sequencing template will typically also reduce the costs of the following sequencing. With the advent of robotic DNA extraction and pipetting, the whole process has also the potential to be fully automated, and controlled very effectively and conveniently by a qualified microbiologist who can handle large amounts of analyzed cultures in parallel. To conclude, the speed, power, convenience and cost of HRMA, presages that this technology will advance genetic characterization of microbes related to patients and substantially enrich current procedures in routine medical microbiology.
